Microablative Fractional CO 2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up.

MLA

Salvatore, Stefano, et al. “Microablative Fractional CO 2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-Week Follow-Up.” Clinical Breast Cancer, vol. 21, no. 5, Oct. 2021, pp. e539–46. EBSCOhost, https://doi.org/10.1016/j.clbc.2021.01.006.

APA

Salvatore, S., Nappi, R. E., Casiraghi, A., Ruffolo, A. F., Degliuomini, R., Parma, M., Leone Roberti Maggiore, U., Athanasiou, S., & Candiani, M. (2021). Microablative Fractional CO 2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up. Clinical Breast Cancer, 21(5), e539–e546. https://doi.org/10.1016/j.clbc.2021.01.006

Chicago

Salvatore, Stefano, Rossella E Nappi, Arianna Casiraghi, Alessandro F Ruffolo, Rebecca Degliuomini, Marta Parma, Umberto Leone Roberti Maggiore, Stavros Athanasiou, and Massimo Candiani. 2021. “Microablative Fractional CO 2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-Week Follow-Up.” Clinical Breast Cancer 21 (5): e539–46. doi:10.1016/j.clbc.2021.01.006.